DNMT1 and acute myeloid leukemia: A potentially important target in AML.DNMT1 is 5.3 fold overexpressed in AML cells compared with the control bone marrow cells [103].A recently characterized DNMT1-specific inhibitor showed better efficacy with improved tolerability against AML in vitro and in vivo [104].